|
|
DSpace at RU >
Browsing by Author Wesseling, J.
Showing results 1 to 8 of 8
| Full Text | Issue Date | Title | Author(s) | | 2011 | The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients | Schaik, R.H. van; Kok, M. de; Sweep, F.C.; Vliet, M. van; Fessem, M. van, et al |
| 2011 | Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma | Hartog, H.; Horlings, H.M.; Vegt, B. van der; Kreike, B.; Ajouaou, A., et al |
| 2010 | Receptor conversion in distant breast cancer metastases. | Hoefnagel, L.D.; Vijver, M.J. van de; Slooten, H.J. van; Wesseling, P.; Wesseling, J., et al |
| 2009 | CHECK (Cohort Hip and Cohort Knee): similarities and differences with the Osteoarthritis Initiative. | Wesseling, J.; Dekker, J.; Berg, W.B. van den; Biersma-Zeinstra, S.M.; Boers, M., et al |
| 2009 | Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels. | Vrieling, A.; Voskuil, D.W.; Bosma, A.; Majoor, D.M.; Doorn, J. van, et al |
| 2008 | Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples. | Hartog, H.; Graaf, W.T.A. van der; Wesseling, J.; Veer, E. van der; Boezen, H.M. |
| 2007 | The insulin-like growth factor 1 receptor in cancer: old focus, new future. | Hartog, H. de; Wesseling, J.; Boezen, H.M.; Graaf, W.T.A. van der |
| 2005 | Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. | Leegte, B.; Hout, A.H. van der; Deffenbaugh, A.M.; Bakker, M.K.; Mulder, I.M., et al |
Showing results 1 to 8 of 8
|